These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33059476)

  • 21. Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs.
    Schulman EA; Dermott KF
    Headache; 2003; 43(7):729-33. PubMed ID: 12890127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.
    Ben Aissa M; Tipton AF; Bertels Z; Gandhi R; Moye LS; Novack M; Bennett BM; Wang Y; Litosh V; Lee SH; Gaisina IN; Thatcher GR; Pradhan AA
    Cephalalgia; 2018 Jul; 38(8):1471-1484. PubMed ID: 29022756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of glyceryl trinitrate provoked mast cell degranulation.
    Pedersen SH; Ramachandran R; Amrutkar DV; Petersen S; Olesen J; Jansen-Olesen I
    Cephalalgia; 2015 Dec; 35(14):1287-97. PubMed ID: 25724914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.
    Tipton AF; Tarash I; McGuire B; Charles A; Pradhan AA
    Cephalalgia; 2016 Oct; 36(11):1048-1056. PubMed ID: 26682574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CGRP antagonists: hope for a new era in acute migraine treatment.
    Schelstraete C; Paemeleire K
    Acta Neurol Belg; 2009 Dec; 109(4):252-61. PubMed ID: 20120204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sumatriptan Does Not Antagonize CGRP-Induced Symptoms in Healthy Volunteers.
    Falkenberg K; Rønde Bjerg H; Yamani N; Olesen J
    Headache; 2020 Apr; 60(4):665-676. PubMed ID: 31944310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia.
    Linde M; Elam M; Lundblad L; Olausson H; Dahlöf CG
    Cephalalgia; 2004 Dec; 24(12):1057-66. PubMed ID: 15566420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD; Goadsby PJ; Roon KI; Lipton RB
    Cephalalgia; 2002 Oct; 22(8):633-58. PubMed ID: 12383060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-migraine Calcitonin Gene-Related Peptide Receptor Antagonists Worsen Cerebral Ischemic Outcome in Mice.
    Mulder IA; Li M; de Vries T; Qin T; Yanagisawa T; Sugimoto K; van den Bogaerdt A; Danser AHJ; Wermer MJH; van den Maagdenberg AMJM; MaassenVanDenBrink A; Ferrari MD; Ayata C
    Ann Neurol; 2020 Oct; 88(4):771-784. PubMed ID: 32583883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Getting to the Heart of the Matter: Migraine, Triptans, DHE, Ditans, CGRP Antibodies, First/Second-Generation Gepants, and Cardiovascular Risk.
    Mathew PG; Klein BC
    Headache; 2019 Sep; 59(8):1421-1426. PubMed ID: 31318457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting CGRP and 5-HT
    Moreno-Ajona D; Chan C; Villar-Martínez MD; Goadsby PJ
    Headache; 2019 Jul; 59 Suppl 2():3-19. PubMed ID: 31291016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans.
    Diamond S; Freitag FG; Feoktistov A; Nissan G
    J Headache Pain; 2007 Feb; 8(1):13-8. PubMed ID: 17221340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proinflammatory mediators and migraine pathogenesis: moving towards CGRP as a target for a novel therapeutic class.
    Farinelli I; Missori S; Martelletti P
    Expert Rev Neurother; 2008 Sep; 8(9):1347-54. PubMed ID: 18759547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WITHDRAWN: Oral sumatriptan for acute migraine.
    McCrory DC; Gray RN
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD002915. PubMed ID: 22336784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral sumatriptan for acute migraine.
    McCrory DC; Gray RN
    Cochrane Database Syst Rev; 2003; (3):CD002915. PubMed ID: 12917936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
    Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
    J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.